Submission of Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supha Pharmachem has submitted a routine compliance certificate to BSE under SEBI's Regulation 74(5), which relates to the dematerialisation and rematerialisation of shares. The certificate was issued by the company's Registrar and Share Transfer Agent, Bigshare Services Pvt Ltd. The Registrar confirmed that the regulation is not applicable for the quarter ended 31 December 2025, as all of the company's shares are already held in dematerialised (electronic) form and no shareholder requested any physical-to-electronic or electronic-to-physical conversion during the quarter. This is a standard quarterly compliance filing with no change in share structure or shareholding pattern.
No impact on shareholders or the stock price. This is a routine regulatory disclosure confirming that all shares remain in demat form, indicating no material corporate action or shareholding change during the quarter.